Inhibition of hepatic gluconeogenesis and fatty acid oxidation by pent-4-enoic acid.
D000409:Alanine / Q000378:metabolism; D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D002210:Caprylates / Q000378:metabolism; D002245:Carbon Dioxide; D005230:Fatty Acids, Nonesterified / Q000378:metabolism*; D005632:Fructose / Q000378:metabolism; D005663:Furans / Q000494:pharmacology*; D005943:Gluconeogenesis / Q000187:drug effects*; D005947:Glucose / Q000378:metabolism; D005990:Glycerol / Q000378:metabolism; D007657:Ketone Bodies / Q000378:metabolism; D007783:Lactones / Q000494:pharmacology*; D008099:Liver / Q000166:cytology / Q000201:enzymology / Q000378:metabolism*; D010084:Oxidation-Reduction; D010477:Perfusion; D011868:Radioisotopes; D051381:Rats
D002210:Caprylates; D005230:Fatty Acids, Nonesterified; D005663:Furans; D007657:Ketone Bodies; D007783:Lactones; D011868:Radioisotopes; D002245:Carbon Dioxide; D005632:Fructose; D001224:Aspartic Acid; D005947:Glucose; D000409:Alanine; D005990:Glycerol